Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Company price
0.048 AUD 0.00(0%)
Last update at 2026-11-18T23:22:00Z
VOLUME
48
Market Cap
2.63M

Momentum Score

…

Adherium Limited, a digital health company, develops, manufactures, and supplies digital health technologies that address sub-optimal medication use and improve health outcomes in chronic diseases. The company offers Hailie Smartinhaler, a cloud-based platform which captures medication use data from Bluetooth enabled sensors which wrap around patient inhalers and provide real-time feedback to patients; Hailie Smartinhaler Sensors, a device coverage that works for Rescuer/Reliever and Preventer inhalers; Hailie solution; and Hailie Remote Patient Monitoring (RPM) Solution. It operates in New Zealand, Australia, South East Asian Countries, and North America. Adherium Limited was founded in 2001 and is based in Melbourne, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.05
Low
0.05
High
52 Week Price Range
0.05
Low
0.67
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Adherium Ltd develops digital inhaler sensors and a cloud-based adherence platform for asthma and COPD to record inhaler use and enable remote monitoring. Long-term growth may be supported by rising adoption of digital health, recurring device and data services, and partnerships with healthcare organisations and pharmaceutical companies, making it relevant to investors interested in respiratory digital tools.
Key risks include limited scale and revenue, execution and commercialisation challenges, competitive pressure, regulatory and reimbursement uncertainty, and potential need for additional capital.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.05
Dividend Yield
-
Revenue TTM
2.10M
Revenue Per Share
0.04
Gross Profit TTM
1.22M
Debt / Equity
-1.86
ROE
-4073.34%
Net Debt
0.98M
ROCE
1131.05%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax -15.26M -12.68M -10.22M -9.86M -11.22M
Net income -14.16M -12.68M -10.22M -9.86M -11.22M
Selling general administrative - 5.49M 5.06M 4.85M 5.36M
Selling and marketing expenses - 4.29M 2.14M 4.01M 0.94M
Gross profit 1.22M 0.11M 0.27M 2.52M 0.32M
Reconciled depreciation - - 0.11M 0.19M 0.18M
Ebit - -12.54M -11.67M -9.85M -11.22M
Ebitda -14.36M -12.44M -11.56M -9.66M -11.04M
Depreciation and amortization - 0.10M 0.11M 0.19M 0.18M
Operating income -14.36M -12.54M -12.09M -9.85M -11.22M
Other operating expenses 16.46M 13.36M 12.93M 15.28M 13.59M
Interest expense 0.96M 0.23M 0.00M 0.01M 0.00M
Tax provision - 0.00M 0.00M 0.00M 0.00M
Interest income - 0.14M 0.24M 0.20M 0.02M
Net interest income - - 0.24M 0.20M 0.02M
Income tax expense -1.09M - -1.45M 1.84M 0.00M
Total revenue 2.10M 0.82M 0.84M 3.19M 0.53M
Total operating expenses 15.58M 12.65M 12.36M 14.61M 13.38M
Cost of revenue 0.88M 0.71M 0.57M 0.67M 0.21M
Total other income expense net -0.90M -0.14M 1.87M 1.84M -0.00M
Net income from continuing ops - - -10.22M -9.86M -11.22M
Net income applicable to common shares - -12.68M -10.22M -9.86M -11.22M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 4.56M 3.52M 9.89M 12.68M 7.36M
Intangible assets - 0.00M - 0.04M 0.00M
Other current assets 0.11M 1.44M 0.15M 0.23M 0.27M
Total liab 5.85M 8.28M 3.41M 3.47M 3.00M
Total stockholder equity -1.29M -4.76M 6.48M 9.21M 4.36M
Other current liab 0.30M 2.04M - 1.81M 1.21M
Common stock 149.66M 132.13M 131.00M 123.62M 110.52M
Capital stock - - - 123.62M 110.52M
Retained earnings -130.35M -116.19M 103.51M -93.29M -84.61M
Other assets - - 0.00M - -
Cash 1.42M 0.04M 6.20M 9.08M 5.28M
Cash and equivalents - - - 9.08M 5.28M
Total current liabilities 5.83M 8.25M 3.36M 3.47M 2.95M
Current deferred revenue 0.49M - 0.57M 0.66M 1.21M
Net debt 0.98M 3.08M -6.10M -9.03M -5.20M
Short term debt 2.40M 3.12M 0.05M 0.04M 0.04M
Short long term debt total 2.40M 3.12M 0.09M 0.04M 0.09M
Other stockholder equity - - -249.05M -21.12M -21.55M
Property plant equipment - - - 0.13M 0.31M
Total current assets 4.50M 3.40M 9.73M 12.51M 7.05M
Net tangible assets - - - 9.21M 4.36M
Net receivables 1.74M 0.08M 1.80M 1.97M 0.42M
Inventory 1.23M 1.84M 1.58M 1.24M 1.07M
Accounts payable 2.63M 3.09M 2.75M 0.96M 1.70M
Accumulated other comprehensive income -20.59M -20.71M 21.01M -21.12M -21.55M
Non currrent assets other - - 0.00M - -
Non current assets total 0.07M 0.12M 0.16M 0.17M 0.31M
Capital lease obligations - - - 0.04M 0.09M
Long term debt total - - - 0.00M 0.04M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments - - -0.00M -0.04M -0.28M
Change to liabilities - - - 0.34M 0.05M
Total cashflows from investing activities -0.04M -0.05M -0.00M -0.04M -0.28M
Total cash from financing activities 16.32M 3.87M 7.73M 13.07M 1.43M
Net income -14.16M -12.68M -10.22M -9.86M -10.04M
Change in cash 1.38M -6.15M -2.88M 3.79M -9.89M
Begin period cash flow 0.04M 6.20M 9.08M 5.28M 15.18M
End period cash flow 1.42M 0.04M 6.20M 9.08M 5.28M
Total cash from operating activities -14.83M -9.98M -10.61M -9.28M -9.61M
Issuance of capital stock - - 8.37M 13.81M -
Depreciation - 0.10M 0.11M 0.19M 0.19M
Other cashflows from investing activities - - 0.00M - -
Change to inventory - -0.23M -0.35M -0.15M -0.14M
Change to account receivables - 0.18M -0.09M -0.30M -1.19M
Sale purchase of stock - - -0.64M -0.74M 0.00M
Other cashflows from financing activities - - -0.00M -0.04M -0.28M
Change to netincome - - - 0.50M 1.53M
Capital expenditures 0.04M 0.05M 0.00M 0.04M 0.28M
Change in working capital - 2.46M -0.82M -0.11M -1.28M
Stock based compensation - 16.32M - 0.52M 1.50M
Other non cash items -0.67M -16.19M 0.43M 0.42M 3.76M
Free cash flow -14.87M -10.03M -10.61M -9.32M -9.89M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
ADR
Adherium Ltd
-
-%
0.05 - 0.91 1.25 2.84 1.72 -0.20
COH
Cochlear Ltd
-3.88
2.52%
149.99 68.39 29.76 4.29 5.75 4.28 30.27
IMR
Imricor Medical Systems Inc
0.01
1.15%
1.32 - - 16567.91 17.45 4019.33 -2.60
AVH
Avita Medical Inc
-0.40
7.84%
4.70 - 9.97 9.54 7.17 6.33 15.37
AVR
Anteris Technologies Global Corp
-0.33
4.19%
7.55 - - 329.44 2.32 145.60 -5.20

Profile*

Adherium Ltd

Adherium Limited, a digital health company, develops, manufactures, and supplies digital health technologies that address sub-optimal medication use and improve health outcomes in chronic diseases. The company offers Hailie Smartinhaler, a cloud-based platform which captures medication use data from Bluetooth enabled sensors which wrap around patient inhalers and provide real-time feedback to patients; Hailie Smartinhaler Sensors, a device coverage that works for Rescuer/Reliever and Preventer inhalers; Hailie solution; and Hailie Remote Patient Monitoring (RPM) Solution. It operates in New Zealand, Australia, South East Asian Countries, and North America. Adherium Limited was founded in 2001 and is based in Melbourne, Australia.

447 Collins Street, Melbourne, VIC, Australia, 3000

61 426 800 680

Name Title Year Born
Mr. Rick Legleiter B.S., M.B.A. Chief Exec. Officer 1959
Mr. Geoff Feakes Chief Technology Officer NA
Mr. Rob Turnbull B.Com., C.A., B.Com, CA. GM & Joint Company Sec. 1967
Mr. Mark Andrew Licciardo B Bus (Acc), FCIS, FGIA, GAICD, GradDip CSP Joint Company Sec. 1964
Mr. Daniel Kaplon Chief Financial Officer NA
Ms. Kirsty Rutledge-Malyon HR Mang. NA
Ms. Maggie Scott Head of Clinical Operations NA
Mr. Michael Motion Consultant NA
Dr. John Douglas Wilson Exec. Medical Director 1937
Mr. Louis James Panaccio BEC, C.A., M.A.I.C.D. Executive Chairman of the Board 1957

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…